FDA Inspection
OneBlood, Inc.OneBlood, Inc. – FDA Inspection, May 5, 2022
Record Details
This FDA Inspection record concerns OneBlood, Inc., with an inspection on May 5, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- OneBlood, Inc.
- Inspection Date
- May 5, 2022
- Product Type
- Biologics
View Company Profile
ID · 705e050d-fb5b-484a-9f93-9965aac6a385
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1169171
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of OneBlood, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 20, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 5, 2017 | Not classified | Florida District Office | |
| June 4, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 31, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 23, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for OneBlood, Inc.
- FDA Inspection 1081725 - 2019-02-20
- FDA Inspection 1001759 - 2017-01-05
- FDA Inspection 881683 - 2014-06-04
- FDA Inspection 784669 - 2012-05-31
- FDA Inspection 669425 - 2010-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.